ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
LEO Pharma enters clinical trial partnership with ICON
This news article, published on PM Live, highlights how the partnership will advance trial execution within medical dermatology.
LEO Pharma and ICON plc collaborate to improve outcomes for dermatology patients
This article, published on Outsourcing Pharma, covers the strategic partnership between LEO Pharma and ICON.
The contribution of companies during the Covid-19 pandemic
Rose Kidd outlines the role ICON played in the search for vaccines and treatments for Covid-19 in the American Chamber of Commerce Ireland 2023 US-Ireland Business Report.
LEO Pharma and ICON partner for clinical trial execution in dermatology
This news article outlines how the collaboration is expected to provide access to innovative clinical trials as well as help to launch new medicines.
LEO Pharma and ICON enter strategic partnership
ICON and LEO Pharma have announced a strategic partnership to scale patient-centric and cost-effective clinical trials.
ICON and LEO Pharma join forces on clinical trial mission
This news article, published on PharmaTimes online, indicates how the collaboration will concentrate on launching and running studies within medical dermatology.
LEO Pharma, ICON partner to advance clinical trials in dermatology
This news article covers the strategic partnership between LEO Pharma and ICON to propel clinical trial execution within medical dermatology.
Strategies for building greater DE&I in Rare Disease trials
This article describes some factors that produce barriers in the rare disease drug development process and identifies strategies to improve diversity in these trials.
Optimising biotech trial designs to stretch your cash runway
Brandon Early discusses how optimising trials designs at the earliest stages can help innovative biotech companies to maximise their available capital.
As clinical trials face a hiring crunch, here’s how research organisations can pivot
Helen Yeardley, Senior Vice President, Global Clinical Operations, discusses how ICON is adapting to the global shortage of Clinical Research Associates in the industry.